Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.

Tamura, Ryota; Fujioka, Masato; Morimoto, Yukina; Ohara, Kentaro; Kosugi, Kenzo; Oishi, Yumiko; Sato, Mizuto; Ueda, Ryo et al. · Nat Commun · 2020

Where this comes from

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.